| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |